Harish Shantharam - 21 Jan 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Financial Officer
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
21 Jan 2025
Net transactions value
$0
Form type
4
Filing time
23 Jan 2025, 18:19:33 UTC
Previous filing
22 Mar 2024
Next filing
15 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +600,000 $0.000000 600,000 21 Jan 2025 Common Stock 600,000 $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on January 21, 2026 and 1/48 of the shares vest monthly thereafter.